Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Uterine Cancer Clinical Trial

Official title:

Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06401265
• Other study ID #: 06-X34-105
• Status: Completed
• Start date: January 1, 2018
• Est. completion date: September 5, 2022

Study information

• Verified date: February 2022
• Source: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Among urothelial cancers, upper urinary tract urothelial cancers, including renal pelvis and ureteral cancers have a higher incidence rate in Taiwan than Western countries. In particular, the proportion of female patients is similar to that of males. This situation is significantly different from that in foreign countries. The cause is currently uncertain.In the past, the arsenic contamination of groundwater made blackfoot disease become common and malignant in areas. Now, the number of kidney dialysis patients in Taiwan is increasing; and according to statistics, there is a significantly higher incidence of urothelial cancer among kidney dialysis patients. This may be caused by the use of traditional Chinese medicine or other unknown reasons.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8000
• Est. completion date: September 5, 2022
• Est. primary completion date: February 8, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Case study of upper urinary tract urothelial cancer surgery

Exclusion Criteria:

• Cases of surgery for non-upper urinary tract urothelial cancer

Related Conditions & MeSH terms

• Uterine Cancer
• Uterine Neoplasms

Locations

Country	Name	City	State
Taiwan	Tzu Chi hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	It is a retrospective and questionnaire-based study.		Patients with urothelial carcinoma of the upper urinary tract from January 2008 to December 2019.